glp 1 studies GLP-1 Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response GLP-1 receptor agonists | How

Discover the serious yet rare side effects of Ozempic, including pancreatitis, thyroid cancer, and more, plus expert insights.

Among the marketed large molecule injectable GLP-1 agonists, semaglutide, apart from weight-loss, is being studied for kidney disease and tirzepatide (a dual GLP-1 and GIP receptor agonist) is being evaluated for sleep apnea in Ph 3 clinical trials

More and more evidence is showing that the use of DPP4 Inhibitors and GLP1 Receptor Agonists in combination, is a practice worth changing

What to eat to balance your blood sugar and lose weight

Effectiveness and Impact Significant Weight Loss: Phase 2 studies showed up to roughly 20% average body weight loss at 52 weeks in participants with obesity

We report an unusual case of diabetic ketoalkalosis, a mixed acid-base disorder, in a 57-year-old female patient with insulin-dependent T2DM following a switch to Mounjaro (tirzepatide)